• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SEKINE YUYA  関根 悠哉

ORCIDConnect your ORCID iD *help
Researcher Number 10974834
Other IDs
Affiliation (Current) 2026: 秋田大学, 医学部附属病院, 助教
Affiliation (based on the past Project Information) *help 2024 – 2025: 秋田大学, 医学部附属病院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 56030:Urology-related
Except Principal Investigator
Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields / Basic Section 56030:Urology-related
Keywords
Principal Investigator
尿路上皮癌 / ラジオゲノミクス / 泌尿器科悪性腫瘍
Except Principal Investigator
腎細胞癌 / 複合療法 / 単一細胞解析 / CTLA-4 / PD-L1 / PD-1 / バイオマーカー … More / 腫瘍微小環境 / 免疫チェックポイント阻害薬 / ゲノム解析 / 両側腎癌 / 両側 Less
  • Research Projects

    (3 results)
  • Research Products

    (1 results)
  • Co-Researchers

    (7 People)
  •  Radiogenomicsを用いた尿路上皮癌FGFR遺伝子変異予測モデルの構築Principal Investigator

    • Principal Investigator
      関根 悠哉
    • Project Period (FY)
      2025 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Akita University
  •  両側腎細胞癌に対するゲノム解析

    • Principal Investigator
      沼倉 一幸
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Akita University
  •  腎癌に対する免疫チェックポイント阻害薬抵抗性の克服

    • Principal Investigator
      嘉島 相輝
    • Project Period (FY)
      2024 – 2028
    • Research Category
      Fund for the Promotion of Joint International Research (International Collaborative Research)
    • Review Section
      Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields
    • Research Institution
      Akita University

All 2024

All Journal Article

  • [Journal Article] The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy2024

    • Author(s)
      Numakura Kazuyuki、Sekine Yuya、Osawa Takahiro、Naito Sei、Tokairin Ojiro、Muto Yumina、Sobu Ryuta、Kobayashi Mizuki、Sasagawa Hajime、Yamamoto Ryohei、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Akashi Hideo、Tsuchiya Norihiko、Shinohara Nobuo、Habuchi Tomonori
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 29 Issue: 7 Pages: 1019-1026

    • DOI

      10.1007/s10147-024-02538-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23K21469, KAKENHI-PROJECT-24K12502
  • 1.  沼倉 一幸 (90566415)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 2.  小林 瑞貴 (20838627)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  桃沢 幸秀 (40708583)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  嘉島 相輝 (50842952)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  成田 伸太郎 (40396552)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  羽渕 友則
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 7.  土谷 順彦
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi